Trial of Sibeprenlimab in the Treatment of A Nephropathy (IgAN)
Clinical trial NCT05248646 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05248646
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-03-15
- Primary completion
- 2026-05-13
- Enrollment
- 530
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.